Brufen
PreclinicalSmall molecule
Boehringer IngelheimBrufen is one of 5 small molecule programs targeting Pain. It is currently in Preclinical.
2
Indications
4
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Premedication
#DrugCompanyPhaseTrials
1Duragesic
CCephalon
Approved
Ketalar
AAultman Health Foundation
Approved
Robinul
Jazz PharmaceuticalsPreclinical
Brufen
Boehringer IngelheimPreclinical
No Premedication
YYonsei University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Premedication1 trial
Effectiveness of Buccal Infiltration During Vital Pulpotomy After Administering Two Analgesic Premedications
Completed·—·N/A·NCT03423329·60 enrolled
Ibuprofen1 trial
Low back pain1 trial
Pain1 trial
Role of Alprazolam in Management of Post Endodontic Pain After Single Visit Root Canal Treatment
Recruiting·AArmed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi·Preclinical·NCT07275710·110 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Brufen. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company